NCT03180736 2025-12-19EMN14European Myeloma Network B.V.Phase 3 Completed304 enrolled 19 charts 1 FDA
NCT05028348 2025-12-04A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple MyelomaEuropean Myeloma Network B.V.Phase 3 Active not recruiting117 enrolled